Skip to main content

Find Clinical Trials

Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation

NCT00487656

Conditions: Blood Coagulation Disorders, Disseminated Intravascular Coagulation, Hematologic Diseases, +9 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Tuscon, Arizona, United States

Bakersfield, California, United States

View all 62 locations

View Trial Details

Completed

Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

NCT00806767

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France

View Trial Details

Completed

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

NCT00661999

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +72 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00609167

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients

NCT00752518

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: Not specified

View Trial Details

Completed

An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy

NCT00216697

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

NCT00602706

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment

NCT00802568

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France

View Trial Details

Completed

Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma

NCT00616720

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00618345

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details